Morocco Launches First Exports of Medical Cannabis, Marking a Milestone in Pharmaceutical Industry
On April 10, 2025, Morocco began exporting its first medical cannabis batches, particularly the "Beldia" strain, to select African countries and Switzerland. This initiative, following the 2021 legalization, reflects Morocco's commitment to the cannabis industry, enhancing its pharmaceutical sector, supporting local farmers, and targeting a growing global market.
hassan benyoub 
Casablanca, April 12, 2025 – Morocco has begun exporting its first batches of medical cannabis, specifically the “Beldia” strain, to select African countries and Switzerland. The shipments, which departed on Thursday, April 10, 2025, mark a historic step for the nation’s pharmaceutical industry and reflect Morocco’s commitment to the legal use of cannabis for medical and industrial purposes.
Details of the Export Operation
The initial shipments originated from a processing unit operated by the Biocannat cooperative in the Bab Berred commune of Chefchaouen province, a region long associated with cannabis cultivation. The consignments were transported to Mohammed V International Airport in Casablanca before being dispatched to specialized pharmaceutical laboratories in Europe and Africa. This move follows Morocco’s 2021 legalization of cannabis for medical and industrial use, aiming to integrate its traditional cultivation expertise into the global market while ensuring strict regulatory oversight.
A New Era for Morocco’s Pharmaceutical Sector
Morocco’s entry into the medical cannabis export market positions it as a pioneer in the region, capitalizing on the growing global demand for cannabis-based treatments. The “Beldia” strain, a local variety known for its resilience and unique properties, is expected to cater to pharmaceutical companies producing treatments for conditions such as chronic pain, epilepsy, and cancer-related symptoms. This initiative not only boosts Morocco’s economy but also supports local farmers in the Rif region by providing a legal framework for their trade, reducing illicit activities .
Strategic Implications
The exports to Switzerland and African nations signal Morocco’s ambition to become a key player in the global medical cannabis industry, projected to reach $55 billion by 2027. By targeting both European and African markets, Morocco aims to diversify its export portfolio while fostering regional cooperation in healthcare innovation. The move aligns with the country’s broader strategy to modernize its agricultural sector and promote sustainable development .
Conclusion
Morocco’s first medical cannabis exports mark a transformative moment for its pharmaceutical industry, blending tradition with innovation. As the kingdom navigates this new frontier, the success of this venture could pave the way for expanded production and further international partnerships, solidifying Morocco’s role in the global medical cannabis market.
